Hyperthermia inhibits growth of nasopharyngeal carcinoma through degradation of c-Myc

References

• Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5(5):423–428.
   PubMed Web of Science ®Google Scholar
• Chang JT, See LC, Liao CT, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000;54(2):135–142.
   PubMed Web of Science ®Google Scholar
• Bensouda Y, Kaikani W, Ahbeddou N, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(2):79–85.
   PubMed Web of Science ®Google Scholar
• Chua MLK, Wee JTS, Hui EP, et al. Nasopharyngeal carcinoma. Lancet (London, England). 2016;387(10022):1012–1024.
   PubMed Web of Science ®Google Scholar
• Lai SZ, Li WF, Chen L, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80(3):661–668.
   PubMed Web of Science ®Google Scholar
• Cheng SK, Dizon J. Computerised cognitive behavioural therapy for insomnia: a systematic review and Meta-analysis. Psychother Psychosom. 2012;81(4):206–216.
   PubMed Web of Science ®Google Scholar
• Guo Q, Pan J, Zong J, et al. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Medicine (Baltimore). 2015;94(20):e808.
   PubMed Web of Science ®Google Scholar
• Qi D, Hu Y, Li J, et al. Hyperthermia induces apoptosis of 786-O cells through suppressing Ku80 expression. PloS One. 2015;10(4):e0122977.
   PubMed Web of Science ®Google Scholar
• Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–1279.
   PubMed Web of Science ®Google Scholar
• van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch deep hyperthermia group. Lancet (London, England). 2000;355(9210):1119–1125.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized High-Risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol. 2018;4(4):483–492.
   PubMed Web of Science ®Google Scholar
• Colombo R, Salonia A, Leib Z, et al. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU International. 2011;107(6):912–918.
   PubMed Web of Science ®Google Scholar
• Zheng N, Xu A, Lin X, et al. Whole-body hyperthermia combined with chemotherapy and intensity-modulated radiotherapy for treatment of advanced nasopharyngeal carcinoma: a retrospective study with propensity score matching. Int J Hyperthermia. 2021;38(1):1304–1312.
   PubMed Web of Science ®Google Scholar
• Kang M, Liu WQ, Qin YT, et al. Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastases. Asian Pacific Journal of Cancer Prevention: APJCP. 2013;14(12):7395–7400.
   PubMedGoogle Scholar
• Datta NR, Ordóñez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–753.
   PubMed Web of Science ®Google Scholar
• Dunne M, Regenold M, Allen C. Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy. Adv Drug Deliv Rev. 2020;163–164:98–124.
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LE, Crezee J, et al. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 2015;10:165.
   PubMed Web of Science ®Google Scholar
• Stephen ZR, Zhang M. Recent progress in the synergistic combination of Nanoparticle-Mediated hyperthermia and immunotherapy for treatment of cancer. Adv Healthc Mater. 2021;10(2):e2001415.
   PubMed Web of Science ®Google Scholar
• Moy AJ, Tunnell JW. Combinatorial immunotherapy and nanoparticle mediated hyperthermia. Adv Drug Deliv Rev. 2017;114:175–183.
   PubMed Web of Science ®Google Scholar
• Oei AL, van Leeuwen CM, ten Cate R, et al. Hyperthermia selectively targets human papillomavirus in cervical tumors via p53-dependent apoptosis. Cancer Res. 2015;75(23):5120–5129.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Wu Q, Wu ZB, et al. Microwave hyperthermia promotes caspase‑3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in non‑small cell lung cancer cells. Int J Oncol. 2018;53(2):539–550.
   PubMed Web of Science ®Google Scholar
• Maimaitiyiming Y, Wang QQ, Yang C, et al. Hyperthermia selectively destabilizes oncogenic fusion proteins. Blood Cancer Discov. 2021;2(4):388–401.
   PubMedGoogle Scholar
• Man J, Shoemake JD, Ma T, Rizzo AE, et al. Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling. Cancer Res. 2015;75(8):1760–1769.
   PubMed Web of Science ®Google Scholar
• Luo M, Meng Z, Moroishi T, et al. Heat stress activates Yap/TAZ to induce the heat shock transcriptome. Nat Cell Biol. 2020;22(12):1447–1459.
   PubMed Web of Science ®Google Scholar
• Luo J, Xiao J, Tao Z, et al. Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry. Chin Med J (Engl). 1997;110(3):229–232.
   PubMed Web of Science ®Google Scholar
• Fan CS, Wong N, Leung SF, To KF, et al. Frequent c-myc and int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol. 2000;31(2):169–178.
   PubMed Web of Science ®Google Scholar
• Zheng J, Li W, Huang R. [Studies on c-myc gene expression and p16 gene inactivation in nasopharyngeal carcinoma]. Zhonghua er bi Yan Hou ke za Zhi. 2000;35(6):464–468.
   PubMedGoogle Scholar
• Guo Z, Wang Y, Zhao Y, et al. A functional 5'-UTR polymorphism of MYC contributes to nasopharyngeal carcinoma susceptibility and chemoradiotherapy induced toxicities. J Cancer. 2019;10(1):147–155.
   PubMed Web of Science ®Google Scholar
• Niu Z, Liu H, Zhou M, et al. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2015;47(3):183–191.
   PubMed Web of Science ®Google Scholar
• Yang W, Shen J, Wu M, et al. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene. 2001;20(14):1688–1702.
   PubMed Web of Science ®Google Scholar
• Bretones G, Delgado MD, León J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849(5):506–516.
   PubMed Web of Science ®Google Scholar
• Gearhart J, Pashos EE, Prasad MK. Pluripotency redux-advances in stem-cell research. N Engl J Med. 2007;357(15):1469–1472.
   PubMed Web of Science ®Google Scholar
• Carroll PA, Freie BW, Mathsyaraja H, et al. The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis. Front Med. 2018;12(4):412–425.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23–36.
   PubMed Web of Science ®Google Scholar
• Cotterman R, Jin VX, Krig SR, et al. N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res. 2008;68(23):9654–9662.
   PubMed Web of Science ®Google Scholar
• Deb-Basu D, Karlsson A, Li Q, et al. MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2. Cell Cycle. 2006;5(12):1348–1355.
   PubMed Web of Science ®Google Scholar
• Kim J, Woo AJ, Chu J, Snow JW, et al. A myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell. 2010;143(2):313–324.
   PubMed Web of Science ®Google Scholar
• Dejure FR, Eilers M. MYC and tumor metabolism: chicken and egg. Embo J. 2017;36(23):3409–3420.
   PubMed Web of Science ®Google Scholar
• Casey SC, Baylot V, Felsher DW. MYC: master regulator of immune privilege. Trends Immunol. 2017;38(4):298–305.
   PubMed Web of Science ®Google Scholar
• Han H, Jain AD, Truica MI, et al. Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy. Cancer Cell. 2019;36(5):483–497.e415.
   PubMed Web of Science ®Google Scholar
• Huang MJ, Cheng YC, Liu CR, et al. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol. 2006;34(11):1480–1489.
   PubMed Web of Science ®Google Scholar
• Madden SK, de Araujo AD, Gerhardt M, et al. Taking the myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer. 2021;20(1):3.
   PubMed Web of Science ®Google Scholar
• Skorski T, Perrotti D, Nieborowska-Skorska M, et al. Antileukemia effect of c-myc N3'->P5' phosphoramidate antisense oligonucleotides in vivo. Proc Natl Acad Sci USA. 1997;94(8):3966–3971.
   PubMed Web of Science ®Google Scholar
• Ricker JL, Mata JE, Iversen PL, et al. Gattone VH: c-myc antisense oligonucleotide treatment ameliorates murine ARPKD. Kidney Int. 2002;61(1 Suppl):S125–S131.
   PubMedGoogle Scholar
• Dhanasekaran R, Park J, Yevtodiyenko A, et al. MYC ASO impedes tumorigenesis and elicits oncogene addiction in autochthonous transgenic mouse models of HCC and RCC. Mol Ther Nucleic Acids. 2020;21:850–859.
   PubMedGoogle Scholar
• Habib S, Ariatti M, Singh M. Anti-c-myc RNAi-Based onconanotherapeutics. Biomedicines. 2020;8(12):612.
   PubMed Web of Science ®Google Scholar
• Bidwell GL, 3rd, Davis AN, Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J Control Release. 2009;135(1):2–10.
   PubMed Web of Science ®Google Scholar
• Massó-Vallés D, Soucek L. Blocking myc to treat cancer: Reflecting on two decades of omomyc. Cells. 2020;9(4):883.
   PubMed Web of Science ®Google Scholar
• Song X, Kim SY, Zhou Z, et al. Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human Colon cancer cells. Cell Death Dis. 2013;4(4):e577.
   PubMed Web of Science ®Google Scholar
• Morlé A, Garrido C, Micheau O. Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis. 2015;6(2):e1633.
   PubMed Web of Science ®Google Scholar
• Song X, Kim HC, Kim SY, et al. Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human Colon cancer cells. J Cell Biochem. 2012;113(5):1547–1558.
   PubMed Web of Science ®Google Scholar
• van den Tempel N, Laffeber C, Odijk H, et al. The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination. Oncotarget. 2017;8(27):44593–44604.
   PubMedGoogle Scholar
• Zhong Q, Liu ZH, Lin ZR, et al. The RARS-MAD1L1 fusion gene induces cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clin Cancer Res. 2018;24(3):659–673.
   PubMed Web of Science ®Google Scholar
• Deng X, Liu Z, Liu X, et al. miR-296-3p negatively regulated by nicotine stimulates cytoplasmic translocation of c-Myc via MK2 to suppress chemotherapy resistance. Mol Ther. 2018;26(4):1066–1081.
   PubMed Web of Science ®Google Scholar
• Wang WJ, Wu SP, Liu JB, et al. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res. 2013;73(3):1219–1231.
   PubMed Web of Science ®Google Scholar
• Song AS, Najjar AM, Diller KR. Thermally induced apoptosis, necrosis, and heat shock protein expression in 3D culture. J Biomech Eng. 2014;136(7).
   Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Wroblewski D, Jiang CC, Croft A, Farrelly ML, et al. OBATOCLAX and ABT-737 induce ER stress responses in human melanoma cells that limit induction of apoptosis. PLoS One. 2013;8(12):e84073.
   PubMed Web of Science ®Google Scholar
• Oakes SA. Endoplasmic reticulum stress signaling in cancer cells. Am J Pathol. 2020;190(5):934–946.
   PubMed Web of Science ®Google Scholar
• Tian J, Mo J, Xu L, et al. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. Chem Biol Interact. 2020;327:109184.
   PubMed Web of Science ®Google Scholar
• Ba MC, Long H, Wang S, et al. Hyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death. J Cell Biochem. 2018;119(4):3763–3774.
   PubMed Web of Science ®Google Scholar
• Slimen IB, Najar T, Ghram A, et al. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia. 2014;30(7):513–523.
   PubMed Web of Science ®Google Scholar
• Urano M. Kinetics of thermotolerance in normal and tumor tissues: a review. Cancer Res. 1986;46(2):474–482.
   PubMed Web of Science ®Google Scholar
• Tabuchi Y, Kondo T. Targeting heat shock transcription factor 1 for novel hyperthermia therapy (review). Int J Mol Med. 2013;32(1):3–8.
   PubMed Web of Science ®Google Scholar
• Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int J Hyperthermia. 1995;11(4):459–488.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Joo HJ, Kim YH, et al. Systemic analysis of heat shock response induced by heat shock and a proteasome inhibitor MG132. PLoS One. 2011;6(6):e20252.
   PubMed Web of Science ®Google Scholar
• Arlt A, Bauer I, Schafmayer C, et al. Increased proteasome subunit protein expression and proteasome activity in Colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene. 2009;28(45):3983–3996.
   PubMed Web of Science ®Google Scholar
• Soave CL, Guerin T, Liu J, et al. Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing. Cancer Metastasis Rev. 2017;36(4):717–736.
   PubMed Web of Science ®Google Scholar
• Hui KF, Chiang AK. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism. Int J Cancer. 2014;135(12):2950–2961.
   PubMed Web of Science ®Google Scholar
• Genet SC, Fujii Y, Maeda J, et al. Hyperthermia inhibits homologous recombination repair and sensitizes cells to ionizing radiation in a time- and temperature-dependent manner. J Cell Physiol. 2013;228(7):1473–1481.
   PubMed Web of Science ®Google Scholar
• Ren Y, Bi C, Zhao X, et al. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas. J Clin Invest. 2018;128(12):5517–5530.
   PubMed Web of Science ®Google Scholar
• Mo H, He J, Yuan Z, et al. PLK1 contributes to autophagy by regulating MYC stabilization in osteosarcoma cells. Onco Targets Ther. 2019;12:7527–7536.
   PubMed Web of Science ®Google Scholar
• Xiao D, Yue M, Su H, et al. Polo-like kinase-1 regulates myc stabilization and activates a feedforward circuit promoting tumor cell survival. Mol Cell. 2016;64(3):493–506.
   PubMed Web of Science ®Google Scholar
• Zeller KI, Haggerty TJ, Barrett JF, et al. Characterization of nucleophosmin (B23) as a myc target by scanning chromatin immunoprecipitation. J Biol Chem. 2001;276(51):48285–48291.
   PubMed Web of Science ®Google Scholar
• Krause M, Dubrovska A, Linge A, et al. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv Drug Deliv Rev. 2017;109:63–73.
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LEM, Krawczyk PM, et al. Targeting therapy-resistant cancer stem cells by hyperthermia. Int J Hyperthermia. 2017;33(4):419–427.
   PubMed Web of Science ®Google Scholar
• Li Z, Deng J, Sun J, et al. Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors. Front Immunol. 2020;11:595207.
   PubMed Web of Science ®Google Scholar